Next Generation Dx Summit 2017 | Genome Sequencing Clinical Applications

In this podcast from CHI, on May 11th, 2017 Liz Worthey, Faculty Investigator and Director at HudsonAlpha Institute for Biotechnology sat down to discuss her work in whole genome sequencing to diagnose and monitor rare diseases. She discusses her team’s work with standardizing NGS tests, utilizing sequencing as a diagnostic test, and challenges to making whole genome sequencing standard of care in clinical practice. To learn more, please visit http://www.NextGenerationDx.com/NGS-Based-Assays/